Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-08-19
2009-12-01
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S214020, C514S220000, C514S250000, C514S257000, C514S293000, C540S548000, C540S562000, C540S586000, C544S251000, C544S346000, C546S082000
Reexamination Certificate
active
07625888
ABSTRACT:
The present invention is directed to novel fused triazole derivatives which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DPP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
REFERENCES:
patent: WO 97/03986 (1997-02-01), None
patent: WO 02/076450 (2002-10-01), None
patent: WO 03/000180 (2003-01-01), None
patent: WO 03/000181 (2003-01-01), None
patent: WO 03/004498 (2003-01-01), None
patent: WO 03/082817 (2003-10-01), None
patent: WO 2004/007468 (2004-01-01), None
patent: WO 2004/032836 (2004-04-01), None
patent: WO 2004/037169 (2004-05-01), None
patent: WO 2004/043940 (2004-05-01), None
patent: WO 2004/050022 (2004-06-01), None
patent: WO 2004/058266 (2004-07-01), None
patent: WO 2004/064778 (2004-08-01), None
patent: WO 2004/069162 (2004-08-01), None
patent: WO 2004/110436 (2004-12-01), None
patent: WO 2004/112701 (2004-12-01), None
patent: WO 2005/011581 (2005-02-01), None
patent: WO 2005/044195 (2005-05-01), None
patent: WO 2005/108382 (2005-11-01), None
patent: WO 2005/116029 (2005-12-01), None
patent: WO 2006/066747 (2006-06-01), None
patent: WO 2006/066770 (2006-06-01), None
Demuth, H.U. et al., “Type 2 diabetes—Therapy with dipeptidyl peptidase IV inhibitors” Biochimica et Biophysica Acta, vol. 1751, pp. 33-44, 2005.
Holst, J. J., “Treatment of Type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors” Expert Opin. Emerg. Drugs, vol. 9, No. 1, pp. 155-166, 2004.
Deacon, C. F. et al., “Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?”, Expert Opin. Investig. Drugs, vol. 13, No. 9, pp. 1091-1102, 2004.
Augustyns, K. et al., “Dipeptidyl peptidase IV inhibitors as new therapeutic agents for the treatment of Type 2 diabetes”, Expert Opin. Ther. Patents, vol. 13, No. 4, pp. 499-510, 2003.
“Novel N. substituted-2-cyanopyrrolidines as potent inhibitors of dipeptidyl peptidase IV in the treatment of non-insulin-dependent diabetes mellitus” Exp. Opin. Ther. Patents, vol. 10, No. 12, pp. 1937-1942, 2000.
Drucker, D. J., “Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes” Expert Opin. Investig. Drugs, vol. 12, No. 1, pp. 87-100, 2003.
Vahl, T. P. et al., “Gut peptides in the treatment of diabetes mellitus” Expert Opin. Investig. Drugs, vol. 13, No. 3, pp. 177-188, 2004.
Weber, A. E., “Dipeptidyl Peptidase IV Inhibitors for the Treatment of Diabetes” J. Med. Chem., vol. 47, pp. 4135-4141, 2004.
Holst, J. J. et al., “Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus” Current Opinion in Pharmacology, vol. 4, pp. 589-596, 2004.
Deacon, C. F., “Perspectives in Diabetes—Therapeutic Strategies Based on Glucagon-Like Peptide 1” Diabetes, vol. 53, pp. 2181-2189, 2004.
Augustyns, K. et al., “Inhibitors of proline-specific dipeptidyl peptidases: DPP IV inhibitors as a novel approach for the treatment of Type 2 diabetes” Expert Opin. Ther. Patents, vol. 15, No. 10, pp. 1387-1407, 2005.
Ashton Wallace T.
Weber Ann E.
Durette Philippe L.
Fitch Catherine D.
Kifle Bruck
Merck & Co. , Inc.
LandOfFree
Fused triazole derivatives as dipeptidyl peptidase-IV... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused triazole derivatives as dipeptidyl peptidase-IV..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused triazole derivatives as dipeptidyl peptidase-IV... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4121060